Back to results
US 7,407,945 B2Granted
Use of sulfated glycosaminoglycans for establishing effective labor in women
AssigneeDilafor AB
InventorsGunvor Ekman-Ordeberg, Anders Malmström
Life of this patent
Estimating the term…
Abstract
The invention refers to the use of sulfated glycosaminoglycans having an anticoagulant activity of 100 BP units/mg or less for the manufacture of a pharmaceutical preparation for prophylactic priming or curative treatment of the cervix and the myometrium for establishing effective labor in women.
Claims11
A method for treating protracted term labor in women, comprising the step of:
- administering to a pregnant woman an effective amount of at least one sulfated glycosanilnoglycan selected from the group consisting of heparan sulfate, depolymerised heparan sulfate, dermatan sulfate, depolymerised dermatan sulfate, low molecular weight heparin and depolymerised heparin, said sulfated glycosaminoglycan having an anticoagulant activity of 100 BP units/mg or less to prime or curatively treat the cervix and myometrium and for the treatment of slow progress of term labor.
Dependencies are inferred from the claim text.